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Cell surface glycosaminoglycans (GAGs) are responsible for the majority of respiratory syncytial virus (RSV) attachment
to cultured cells leading to infection. The viral glycoprotein G binds to GAGs and was thought to be the viral attachment
protein, but more recently virus lacking the G protein was shown to be infectious in cell culture. We have compared the GAG
dependence of a recombinant, green fluorescent protein-expressing virus containing the F protein as its only viral glyco-
protein (rgRSV-F) to isogenic complete virus containing all three viral glycoproteins (rgRSV-SGF). Attachment and infection
by each virus was found to be largely dependent on cell surface heparan sulfate (HS) based on the finding that both activities
were inhibited by preincubation of virus with soluble HS, by removal of HS from target cells by enzymatic treatment or
mutation, or by pretreatment of the target cells with basic fibroblast growth factor (bFGF), which binds HS. These results,
coupled with the previous finding that SH is not involved in virion binding (S. Techaarpornkul, N. Barretto, and M. Peeples,
2001, J. Virol. 75, 6825–6834), suggest that, in the context of the virion, both the G and F proteins bind to HS. Interestingly,
both rgRSV-F and rgRSV-SGF retained significant binding activity and infectivity despite these treatments, suggesting an
alternate productive attachment and infection pathway. This property of GAG independence was particularly apparent for
rgRSV-F virions, which retained nearly half of its attachment and infection activities in most of these experiments.
Comparison of the attachment and infection activities of rgRSV-SGF and rgRSV-F virions with a Chinese hamster ovary cell
line and a derivative thereof that is defective in GAG synthesis indicated that approximately 50% of rgRSV-SGF attachment
is due to G protein–GAG binding, 25% to F protein–GAG binding, and 25% to an independent pathway. This alternativeiral sur
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Human respiratory syncytial virus (RSV) is an envel-
oped, negative-strand RNA virus in the Pneumovirinae
subfamily of the Paramyxoviridae family. Human RSV
causes severe lower respiratory tract infection, particu-
larly in infants and older adults. The virion envelope
contains three glycoproteins: the attachment (G) protein;
the fusion (F) protein that initiates fusion of the virion
envelope with a target cell membrane; and the small
hydrophobic (SH) protein of unknown function. Surpris-
ingly, the G and SH proteins are not required for infec-
tivity, as demonstrated by the isolation of a viable RSV
mutant (cp52) lacking these genes (Karron et al., 1997).
Therefore, RSV differs from the viruses in the Paramyxo-
viridae subfamily in that its attachment protein is not
required for infectivity, at least in cultured cells.
To study the function of RSV glycoproteins in the con-
text of virions, we have generated recombinant RSV that© 2002 Elsevier Science (USA)
All rights reserved.
296expresses the green fluorescent protein as a marker
(rgRSV) and carries the genes for each of the four pos-
sible glycoprotein combinations, designated according
to the glycoprotein gene(s) that are present: rgRSV-SGF
(i.e., contains all three surface proteins, SH, G, and F),
rgRSV-GF, rgRSV-SF, and rgRSV-F (Techaarpornkul et al.,
2001). We found that rgRSV-F, which contains the F pro-
tein as its only glycoprotein, can bind to and infect cells
and cause significant cell-to-cell fusion. The G protein
enhances the efficiency of virion binding to a target cell,
the extent of cell-to-cell fusion, and the efficiency of
virion assembly or release. However, once the virion has
attached to a target cell it fuses and enters the cell just
as efficiently, whether the G protein is present or not
(Techaarpornkul et al., 2001).
RSV infection of cultured cells is greatly enhanced by
the presence of glycosaminoglycans (GAGs) on the sur-
face of target cells (Feldman et al., 2000; Hallak et al.,
2000a; Krusat and Streckert, 1997; Martinez and Melero,
2000). Another study suggested that GAGs present onpathway presumably is mediated by the sole remaining v
some other virion-associated protein is involved. © 2002 E
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the virion also could play a role in attachment (Bourgeois
et al., 1998), but this was not confirmed (Hallak et al.,
2000a). Since G protein from detergent-disrupted cells
binds to immobilized heparin, a model GAG (Feldman et
al., 2000; Krusat and Streckert, 1997), and since the
efficiency of infectivity can be reduced by preincubation
of virions with soluble GAGs or by removal of cell surface
GAGs by enzymatic treatment or mutation, it has been
hypothesized that the increase in the efficiency of attach-
ment and infectivity that is mediated by G involves bind-
ing to cell surface GAGs. The SH protein plays no role in
binding or infectivity and may actually have a slightly
inhibitory effect on infectivity and fusion in cell culture
(Bukreyev et al., 1997; Techaarpornkul et al., 2001).
GAGs are long, unbranched polysaccharides com-
posed of repeating disaccharide units. One of the sac-
charides is an amino sugar, either N-acetylglucosamine
(GlcNAc) or N-acetylgalactosamine (GalNAc), and the
other is an uronic acid, either glucuronic acid (GlcA) or
its epimer, iduronic acid (IdoA). Previously, we found that
one cell surface GAG, heparan sulfate (HS), and possibly
a second, chondroitin sulfate B (CS-B), are involved in
RSV attachment to cultured cells. The basic disaccharide
unit of HS is GlcNAc–GlcA/IdoA, modified by the linkage
of sulfate to some of the N groups on GlcNAc and to
some of the 6-O and 2-O positions of GlcNAc and IdoA,
respectively. The basic disaccharide unit of CS-B is Gal-
NAc–IdoA, with some of the GalNAc residues modified
by 4-O-sulfate. We found that the presence of IdoA and
N-linked sulfate were important for RSV infection, but that
sulfation at the 6-O and 2-O positions were not (Hallak et
al., 2000a,b). These findings suggested that there was a
specificity to the binding, rather than being simply a
matter of charge interaction.
Recently, the RSV F protein, similar to its G protein, has
been shown to bind immobilized heparin (Feldman et al.,
2000), though the relative affinities were not determined.
The bovine RSV F protein has also recently been shown
to bind to immobilized heparin, but at a much lower
affinity than the G protein (Karger et al., 2001). The F
protein contains six potential heparin-binding domains
(HBD), including two highly basic furin cleavage sites
(Gonzalez-Reyes et al., 2001; Zimmer et al., 2001), but
whether any of these function as a HBD has not been
tested. Recently, cp52 was shown to use cell surface
GAGs to initiate infection (Feldman et al., 2000), suggest-
ing that the F protein in the context of the virion does
bind to GAGs.
In the present study, we have explored this question
with the matched pair of viruses, rgRSV-SGF and
rgRSV-F. Since the SH protein is not involved in binding
(Techaarpornkul et al., 2001), differences between the
two viruses can be attributed to the G protein and activ-
ities retained by rgRSV-F are likely due to the F protein.
We tested the sensitivity of these viruses to neutraliza-
tion by preincubation with soluble HS, to enzymatic and
mutational removal of HS from the cell surface, and to HS
blocking by preincubation of cells with basic fibroblast
growth factor (bFGF). To analyze the specific GAG struc-
ture bound by each virus, soluble heparin modified by
removal of specific sulfate groups was tested for neu-
tralizing activity, and cells defective in specific GAG sul-
fate modifications were tested for binding and infection
activities. We found that both viruses bound to IdoA-
containing, N-sulfated HS. However, the rgRSV-F was
less dependent on cell surface GAGs for binding and
infection, suggesting that there is another molecule(s) to
which the virus is able to attach and initiate infection.
RESULTS
HS competition for virion binding and infection
HS is the major GAG on the surface of cultured cells
that binds RSV (Feldman et al., 2000; Hallak et al., 2000a;
Martinez and Melero, 2000). Soluble HS is able to neu-
tralize infectivity by interacting with the virion and com-
peting for its attachment to cultured cells. To determine
whether virions lacking the G protein also bind to HS,
35S-labeled, highly purified virions of rgRSV-F and rgRSV-
SGF were prepared as described previously (Techaar-
pornkul et al., 2001). In that article we showed by gel
electrophoresis and phosphorimager analysis that com-
parable counts per minute (cpm) of purified 35S-labeled
virions of these two viruses contained similar amounts of
internal viral proteins, consistent with similar amounts of
virions. These virions also contained similar amounts of
F protein. However, these preparations were not equally
infectious: rgRSV-F bound to target cells with approxi-
mately 30% the efficiency of rgRSV-SGF, and as a result
were 30% as infectious (Techaarpornkul et al., 2001).
An equivalent amount (cpm) of each virion preparation
was mixed with increasing concentrations of HS. HEp-2
cells were inoculated with these mixtures at 4°C, condi-
tions permissive for attachment but not penetration. Fol-
lowing an incubation of 90 min, the cells were washed to
remove unbound virions, and the amount of bound viri-
ons was determined by liquid scintillation counting. On a
parallel set of inoculated plates, the culture medium was
replaced and the plates were incubated at 37°C to allow
infection to proceed. The efficiency of infection was de-
termined at 18 h postinfection (p.i.) by flow cytometric
counting of green fluorescent cells.
Soluble HS inhibited attachment (Fig. 1A) and infection
(Fig. 1B) of rgRSV-SGF in a concentration-dependent
manner with an IC50 of 12.5–25 g/ml, as had been
shown previously for infection (Hallak et al., 2000a). Sol-
uble HS also inhibited attachment and infection of
rgRSV-F. However, the percentage inhibition of treated
rgRSV-F compared to untreated rgRSV-F was less than
that of treated rgRSV-SGF compared to untreated rgRSV-
SGF. These results indicate that some of the virions
containing F as their only surface protein do bind to
GAGs. However, the finding of a large proportion of
rgRSV-F virions that are not inhibited by HS suggest that
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these virions are binding to another surface molecule(s),
representing an alternate pathway that also led to pro-
ductive infection. A smaller proportion of rgRSV-SGF viri-
ons were also resistant to HS inhibition.
Treatment of cells with GAG-specific enzymes
The attachment of rgRSV-SGF to HEp-2 cells is greatly
reduced by pretreating the cells with enzymes that re-
move GAGs from the cell surface (Hallak et al., 2000a). To
determine whether rgRSV-F attachment was similarly
affected, we removed HS by treating cells with hepari-
nase I or heparitinase (heparinase III). Heparinase I
cleaves highly sulfated domains of both heparin and HS,
but since there is no heparin on the cell surface, its
effects would be due to the digestion of HS. Heparitinase
specifically degrades HS, cleaving within poorly sulfated
domains. HS chains contain both highly and poorly sul-
fated domains (Gallagher et al., 1990) and digestion with
either enzyme would release the entire HS chain distal to
the cleavage site. Following these enzymatic treatments,
the cells were incubated with equivalent amounts (cpm)
of purified, radiolabeled rgRSV-SGF and rgRSV-F virions.
Virus attachment and infectivity were determined as de-
scribed above.
Removal of HS by either enzymatic treatment reduced
attachment (Figs. 2A and 3A) and infection (Figs. 2B and
3B) for both viruses, in a concentration-dependent man-
ner. The reduction of both activities was more pro-
nounced for rgRSV-SGF than for rgRSV-F. Heparinase I
decreased rgRSV-SGF binding to 16% (Fig. 2A) and in-
fection to 7% (Fig. 2B), while reducing rgRSV-F binding to
52% and infection to 30% of the untreated levels. Hep-
aritinase reduced rgRSV-SGF binding to 16% (Fig. 3A)
and infection to 9% (Fig. 3B) and reduced rgRSV-F bind-
ing to 67% and infection to 40% of the untreated levels.
The results shown in Figs. 2 and 3 are consistent with
the idea that HS is the key GAG determinant for attach-
ment and infection by rgRSV-SGF (Hallak et al., 2000b;
Martinez and Melero, 2000), as well as rgRSV-F, but also
showed that rgRSV-F was consistently less dependent
on GAGs for binding and infectivity.
To verify that the effects of heparinase I treatment was
due to its HS degradation activity, heparinase I (2.5
mIU/ml) was mixed with increasing concentrations of
soluble heparin, and the mixtures were used to treat
HEp-2 cells. After enzymatic treatment followed by ex-
tensive washing, the cells were inoculated with rgRSV-
FIG. 2. Effect of heparinase I treatment of HEp-2 cells on virion
binding and infection. Confluent monolayers of HEp-2 cells were
treated with heparinase I at 20°C for 1 h, then at 37°C, 5% CO2 for 1 h.
The enzyme was removed and cells were washed three times with
MEM. Cells were inoculated and their ability to bind virions (A) and
their susceptibility to infection (B) was determined as described in the
legend for Fig. 1. Raw cpm bound without enzyme treatment for rgRSV-
SGF and rgRSV-F, respectively, were 5447 and 2181, and infectivity was
35 and 7.5%. As in Fig. 1, treated rgRSV-SGF is compared to untreated
rgRSV-SGF and treated rgRSV-F is compared to untreated rgRSV-F.
FIG. 1. Effect of soluble HS on virion binding (A) and infection (B).
Confluent monolayers of HEp-2 cells were inoculated with 30,000 cpm
of twice sucrose gradient purified, 35S-labeled rgRSV-SGF or rgRSV-F in
the presence of increasing concentrations of soluble HS in MEM, 1%
BSA at 4°C. After 90 min at 4°C, the inocula were removed and cells
were washed to remove unbound virus. (A) To assess binding, cells
were lysed in RIPA buffer and radioactivity was quantified by liquid
scintillation counting. (B) To assess infectivity, OptiMEM–2% FBS was
added to a second set of cells and incubated at 37°C for 18 h. Infected
(green) cells were quantified by flow cytometry. Binding and infection
values for each virus are expressed relative to the activity of the virus
in the absence of HS. Raw cpm bound in the absence of HS for
rgRSV-SGF and rgRSV-F, respectively, were 7933 and 4996, and infec-
tivity was 64 and 17%. Note that the percentage inhibition of each virus
is relative to the homologous untreated control, i.e., treated rgRSV-SGF
is compared to untreated rgRSV-SGF and treated rgRSV-F is compared
to untreated rgRSV-F.
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SGF. Above a concentration of 0.4 mg/ml, soluble heparin
reduced the effectiveness of the enzyme to prevent
rgRSV-SGF binding and infection, in a dose-dependent
manner (Fig. 4). This result confirmed that the treatment
of cells with heparinase I affects virion binding and
infectivity due to its removal of HS.
Competition for virion binding and infection by
chemically modified heparin
Both rgRSV-SGF and rgRSV-F bind to HS, as shown in
Figs. 1–3, but it is possible that they bind to different
aspects of HS. Previously, we found that N-sulfate mod-
ification of the GlcNAc unit (Hallak et al., 2000b), and the
presence of its epimerized counterpart, IdoA, in the
uronic acid position (Hallak et al., 2000a) are the most
important modifications in the cell surface GAGs for
mediating RSV infection. To determine whether rgRSV-
SGF and rgRSV-F require the same HS components, we
compared the competitive activities of unmodified hepa-
rin to that of heparin modified by the chemical removal of
specific sulfate groups.
As shown in Fig. 5, unmodified heparin inhibited in-
fection by each virus, with rgRSV-SGF reduced to 5% and
rgRSV-F reduced to 25%, compared to the untreated
controls. Heparin that had been modified by removal of
the sulfate from the N position of the GlcNAc was inef-
fective, reducing rgRSV-SGF infectivity only to 85% and
rgRSV-F infectivity to 95%. This result demonstrated the
FIG. 3. Effect of heparitinase (heparinase III) treatment of HEp-2 cells
on virion binding and infection. Confluent monolayers of HEp-2 cells
were treated with heparitinase at 20°C for 1 h, then at 37°C, 5% CO2 for
1 h. The enzyme was removed and cells were washed three times with
MEM, and their ability to bind virions (A) and their susceptibility to
infection (B) was determined, as described in the legend for Fig. 1. Raw
cpm bound and infectivity were the same as in the legend for Fig. 2. As
in the preceding figures, treated rgRSV-SGF is compared to untreated
rgRSV-SGF and treated rgRSV-F is compared to untreated rgRSV-F.
FIG. 4. Confirmation that the inhibitory effect of heparinase I treat-
ment on RSV infectivity involves the cleavage of GAGs. Confluent
monolayers of HEp-2 cells were treated with 2.5 mIU/ml of heparinase
I in the presence of increasing concentrations of soluble heparin at
37°C for 1 h, and their ability to bind 35S-labeled rgRSV-SGF virions (A)
and their susceptibility to rgRSV-SGF infection (B) was determined, as
described in the legend for Fig. 1.
FIG. 5. Effect of soluble heparin and chemically modified heparin on
rgRSV-SGF or rgRSV-F attachment. Virus was incubated for 45 min with
OptiMEM alone (Untreated) or containing 10 g/ml of heparin or modified
heparin in which sulfate groups have been removed from specific posi-
tions: the N-linked (De-N-S) or C6-O-linked (De-6O-S) position of glu-
cosamine, or the C2-O-linked (De-2O-S) position of uronic acid. These
mixtures were used to inoculate HEp-2 cells at 37°C for 2 h. The inocula
were removed; growth medium was added, and the cells were incubated
at 37°C. The percentage infected (green) cells was determined by flow
cytometry at 18 h postinoculation. Each value represents an average of
three wells  SD. Raw infectivity values in the absence of inhibitors for
rgRSV-SGF and rgRSV-F, respectively, were 10 and 7%. As in the preceding
figures, treated rgRSV-SGF is compared to untreated rgRSV-SGF and
treated rgRSV-F is compared to untreated rgRSV-F.
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critical nature of the N sulfate group on heparin for its
interaction with both viruses, as had been shown previ-
ously for rgRSV-SGF (Hallak et al., 2000b). Heparin mod-
ified by removal of sulfate from either the 2-O position of
the IdoA or the 6-O position of the GlcNAc reduced
rgRSV-SGF infection to an intermediate extent, 45 and
35%, respectively. The same modifications reduced
rgRSV-F infection to 70 and 45%. These results suggest
that, for both viruses, the sulfate in the 2-O and 6-O
positions play a more minor role than the N sulfate.
Similar to the experiments described above, heparin and
all of the modified heparins showed less inhibitory effect
on rgRSV-F than rgRSV-SGF.
Inhibition of virion binding by bFGF
We previously found that pretreatment of cells with
basic fibroblast growth factor inhibited rgRSV-SGF infec-
tion (Hallak et al., 2000a). Since bFGF binds specifically
to GAGs containing IdoA (Chintala et al., 1994; Turnbull et
al., 1992; Westergren-Thorsson et al., 1993), this obser-
vation had confirmed our speculation that IdoA is a
crucial GAG component for rgRSV-SGF infection. To de-
termine whether IdoA is also important in rgRSV-F infec-
tion, we pretreated cells with bFGF followed by inocula-
tion with either virus. Infection by both rgRSV-SGF and
rgRSV-F was inhibited by bFGF (Fig. 6). As in other
experiments presented here, the inhibitory effect was
greater for rgRSV-SGF than rgRSV-F. This result indicates
that rgRSV-F, similar to rgRSV-SGF, requires IdoA in the
cell surface GAG to which it binds. As described above,
HS contains IdoA in some of its uronic acid positions, as
does CS-B.
Infection of GAG-deficient and sulfation-deficient cell
lines
We had previously shown (Hallak et al., 2000a) that,
relative to the parental CHO (K1) cell line, rgRSV-SGF
does not efficiently infect a derivative CHO cell line
defective in GAG production, A-745. Here, we examined
the sensitivity of this cell line to infection by rgRSV-F, in
comparison to rgRSV-SGF (Fig. 7). Infection with each
virus was less efficient in CHO A-745 cells, confirming
that both viruses use GAGs to attain maximum infectivity.
Once again, rgRSV-SGF was more sensitive to these
defects than was rgRSV-F, 16% vs 56% residual infectivity,
respectively, suggesting again that rgRSV-F is less de-
pendent on GAG binding.
CHO A-745 cells display less than 7% the activity of
xylosyl transferase, compared to the parental K1 cells
(Esko et al., 1985). This enzyme transfers the first sac-
charide of the initial trisaccharide link (xylose–galactose–
galactose) to the core protein. Without this link, the re-
peating disaccharide units of the GAGs cannot be syn-
thesized. The residual xylosyl transferase activity present
in A-745 cells may lead to the synthesis of a small
number of GAGs that are, in turn, responsible for the
remaining susceptibility of these cells to virus infection.
If so, treatment of A-745 cells with heparinase I should
remove much of the remaining ability of these cells to
support infection mediated by GAGs. In Fig. 2B we had
shown that heparinase I pretreatment of HEp-2 cells
greatly reduced infection, to 5%. Treatment of A-745 cells
FIG. 6. Effect of bFGF pretreatment of HEp-2 cells on infection by
rgRSV-SGF and rgRSV-F. Cells were incubated with 10 g/ml bFGF in
Opti-MEM, 2% FBS for 1 h at 4°C. The bFGF was removed, and the cells
rinsed twice with ice cold medium. The inoculum was added, and the
dishes were incubated for 1 h at 4°C. After removing the inoculum, the
cells were rinsed once with medium, medium was added, and the cells
were incubated at 37°C to allow infection to proceed. At 24 h p.i.,
infected (green) cells were counted by flow cytometry. Data presented
are the average of three wells  SD. Raw infectivity values in the
absence of bFGF for rgRSV-SGF and rgRSV-F, respectively, were 43 and
5%. As in the preceding figures, treated rgRSV-SGF is compared to
untreated rgRSV-SGF and treated rgRSV-F is compared to untreated
rgRSV-F.
FIG. 7. Sensitivity of GAG- and sulfation-deficient CHO cell lines to
rgRSV-SGF and rgRSV-F infection. The parental CHO-K1 and mutant
cell lines derived from it, pgsA-745 (GAG deficient), pgsE606 (N-sulfa-
tion deficient), and pgsF-17 (2-O-sulfation deficient), were inoculated
with rgRSV-SGF or rgRSV-F. One set of K1 and A-745 cells were treated
with 5 mIU/ml of heparinase I before inoculation. After adsorption at
4°C for 1 h, the inocula were removed, F-12 medium was added, and
cells were incubated at 37°C. Infected (green) cells were counted by
flow cytometry at 18 h postinoculation. Data are presented relative to
CHO-K1 cells and are the average of three wells  SD. These data are
representative of three separate experiments. Raw infectivity values on
K1 cells for rgRSV-SGF and rgRSV-F, respectively, were 10 and 7%. As
in the preceding figures, treated rgRSV-SGF is compared to untreated
rgRSV-SGF and treated rgRSV-F is compared to untreated rgRSV-F.
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with heparinase I resulted in some reduction in the
ability of A-745 cells to support infection (Fig. 7), from 16
to 13% for rgRSV-SGF, and from 56 to 37% for rgRSV-F.
The remaining susceptibility suggests that a cell surface
molecule other than HS is responsible for a portion of
rgRSV-SGF infectivity, and for a larger portion of rgRSV-F
infectivity.
We previously showed that a CHO cell line defective in
N-sulfation of GlcNAc, E-606 (Esko et al., 1985), was not
efficiently infected by rgRSV-SGF (Hallak et al., 2000b),
indicating that N-sulfation of GAGs is important for RSV
infection. Aside from being an important GAG structural
element, necessary for binding to rgRSV-SGF and
rgRSV-F (Fig. 5), N-sulfation is a prerequisite for two GAG
modifications, namely epimizeration of GluA to IdoA, and
O-sulfation (Bame et al., 1991). Infection of E-606 cells by
rgRSV-SGF or rgRSV-F was 38 and 57% as efficient as
that of the K1 parent (Fig. 7), indicating that either N-
sulfation or its downstream effects, epimizeration or O-
sulfation, is important for the infectivity of both viruses.
We previously showed that a CHO cell line, F-17, de-
fective in IdoA-2-O-sulfotransferase (Bai and Esko, 1996)
was efficiently infected by rgRSV-SGF (Hallak et al.,
2000b). F-17 cells were also efficiently infected by
rgRSV-F (Fig. 7), indicating that 2-O-sulfation of the IdoA
is not critical for the infectivity of either virus.
Virion attachment to CHO K1 and A-745 cells
To obtain a quantitative picture of the roles of GAGs
and virion glycoproteins in cell binding, equal amounts
(20,000 cpm) of purified radiolabeled rgRSV-SGF and
rgRSV-F virions were incubated with the parental CHO
K1 and GAG-deficient A-745 cells. The cpm of each virus
that bound to each cell type was plotted (Fig. 8A). Since
the two 35S-virus preparations had similar specific activ-
ities in terms of internal virion components (not shown),
this experiment provided a direct comparison of the
efficiency of binding of the two viruses. rgRSV-F bound to
K1 cells with 50% the efficiency of rgRSV-SGF, similar to
a comparison of the binding and infectivity of the same
viruses in HEp-2 cells (Techaarpornkul et al., 2001). As
described above, this difference reflects the contribution
of the G protein to binding by rgRSV-SGF. rgRSV-SGF
bound to A-745 cells with approximately 25% the effi-
ciency of K1 cells. Interestingly, rgRSV-F bound to A-745
cells as efficiently as rgRSV-SGF, indicating that the at-
tachment of both viruses to cells lacking GAGs is prob-
ably via a virion surface element that they share, most
likely the F protein.
DISCUSSION
The discovery of a biologically derived RSV deletion
mutant, cp52, that lacked its G gene but retained the
ability to infect (Karron et al., 1997) led both to an eval-
uation of the possible roles of other external virion pro-
teins in attachment (Feldman et al., 2000; Martinez and
Melero, 2000; Techaarpornkul et al., 2001) and to a
search for the receptor(s) used by RSV mutants lacking
the G gene. RSV uses cell surface GAGs to enhance its
binding and therefore infectivity in cultured cells (Hallak
et al., 2000a; Techaarpornkul et al., 2001). Virions lacking
the G protein are less efficient in cell attachment
(Techaarpornkul et al., 2001), confirming a role for the G
protein in attachment. Virions lacking the SH protein do
not differ in their binding activity from those that have the
SH protein, indicating that the SH protein is not involved
in attachment (Techaarpornkul et al., 2001). Initial studies
showed that isolated G protein binds to immobilized
heparin (Krusat and Streckert, 1997), making it the lead-
ing candidate for the virion protein responsible for bind-
ing to cell surface GAGs. However, more recent studies
showed that the F protein of both human and bovine RSV,
similar to their respective G proteins, binds to immobi-
lized heparin (Karger et al., 2001). For bovine RSV, the
binding avidity of the F protein was significantly lower
than that of the G protein (Karger et al., 2001), but this
comparison has not been reported for the human RSV
glycoproteins.
We examined the binding activity of rgRSV-F by com-
petitive inhibition with HS, heparin, and various chemi-
cally modified heparins, following enzymatic removal of
FIG. 8. Binding of rgRSV-SGF and rgRSV-F to CHO K1 and CHO A-745
cells (A). Confluent monolayers of CHO cells were inoculated with
20,000 cpm of twice sucrose gradient purified, 35S-labeled rgRSV-SGF
or rgRSV-F in MEM, 1% BSA. After 90 min at 4°C, the inocula were
removed and cells were washed to remove unbound virus. Cells were
lysed in RIPA buffer and radioactivity was quantified by beta counter.
Here, the viruses can be directly compared, since they have similar
specific activities and the same number of cpm was used. Conceptual
diagram of these results (B).
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HS from the cell surface with heparinase I and hepariti-
nase, following bFGF treatment of the target cells to
occupy binding sites on GAGs that contain IdoA, and in
CHO cell lines defective in GAG production or in specific
GAG sulfation patterns. In each of these situations, the
effect on rgRSV-SGF binding and infectivity has been
mirrored by the effect on rgRSV-F, except that rgRSV-F
appeared to be less sensitive to each modification. The
finding that rgRSV-F was less sensitive to each agent or
treatment suggests that part of the rgRSV-F binding rep-
resents an interaction with a molecule other than a GAG.
In the present experiments, infectivity was measured
by the expression of green fluorescent protein in a sin-
gle-cycle infection. We previously found that recombinant
viruses lacking the G protein, namely rgRSV-SF and
rgRSV-F, were approximately threefold less infectious
than an equivalent amount of rgRSV-SGF virions
(Techaarpornkul et al., 2001). We, therefore, also em-
ployed an assay in which the binding of radiolabeled
virus was quantified directly, permitting a side-by-side
comparison of equal amounts of rRSV-SGF and rgRSV-F
virions.
Figure 8 shows such a comparison of the binding of
rgRSV-SGF and rgRSV-F to wild-type K1 and GAG-defi-
cient A-745 CHO cells. This comparison allows the sep-
aration of virion binding due to the F protein, in rgRSV-F,
from that due to F and G, in rgRSV-SGF, since SH has no
apparent role in binding (Techaarpornkul et al., 2001). It
also allows the separation of virion binding to cellular
GAGs from binding to other molecules. From the data
shown in Fig. 8A, we developed a conceptual diagram
(Fig. 8B) that lead to these following conclusions: (1)
rgRSV-SGF bound to cells lacking GAGs with 25% the
efficiency of cells expressing GAGs, indicating that
GAGs are responsible for 75% of the binding of this virus.
(2) This 25% binding activity of rgRSV-SGF virions to
A-745 cells is similar to that of rgRSV-F virions, indicating
that the G protein is not necessary for virions to bind to
cells via an “alternative molecule(s).” Therefore, all of the
G protein binding activity in this system is due to its
interaction with GAGs. (3) rgRSV-F bound to GAG-ex-
pressing cells with twice the efficiency of GAG-deficient
cells, indicating that a much smaller, though still signif-
icant, proportion of these virions bind to cells via GAGs
even in the absence of the G protein.
One possibility was that some of the alternative mol-
ecule binding might actually be due to GAGs produced
by the reported 7% xylosyl transferase activity remaining
in the A-745 cells (Esko et al., 1985). If so, heparinase I,
which reduced rgRSV-SGF binding to K1 cells by 75%,
would have been able to reduce A-745 binding activity by
a similar amount (Fig. 7). Instead, heparinase I reduced
A-745 binding by a much lower amount, 30% (from 18 to
13%). It is possible that a small portion of the remaining
binding activity is due to undersulfated HS which, if
proximal to the core protein of the proteoglycan, would
not be released by heparinase I, because this enzyme
preferentially digests highly sulfated HS. However, a role
for undersulfated HS seems unlikely since we have
shown that N-sulfation is particularly important for bind-
ing activity (Hallak et al., 2000b). Another possibility is
that a different GAG such as chondroitin sulfate B might
be responsible for some of the alternative molecule bind-
ing. We previously presented evidence that soluble CS-B
is able to block rgRSV-SGF infection of HEp-2 cells,
though 10-fold more CS-B than HS is required, indicating
a very low binding avidity.
We presume that this alternative molecule attachment
is mediated by the F protein, since it is the only viral
glycoprotein remaining on rgRSV-F, and since the mag-
nitude of this pathway is the same for rgRSV-SGF and
rgRSV-F. This is based, for example, on the observation
that rgRSV-SGF and rgRSV-F have an equal ability to bind
to A-745 cells (Fig. 8). Thus, this alternate molecule could
be an “F receptor.” Such appears to be the case for a
herpes simplex virus 1 (HSV-1) mutant lacking both of its
GAG-binding proteins, gB and gC (Herold et al., 1994). A
small proportion of these HSV-1 virions bind to HEp-2
cells, perhaps via a direct interaction between gD and its
specific cell receptor. It is possible that in both wt HSV-1
and rgRSV-SGF, virions bind to target cells via GAGs and
then search in two dimensions, instead of three, until
they contact a specific cell receptor. This approach is
likely to be a more efficient process than binding directly
to a specific receptor.
While the idea of an F receptor is attractive, we have
provided only indirect evidence that the cell binding
activity of rgRSV-F is due to the F protein. It is possible
that another molecule in the virion envelope, incorpo-
rated into the virion from the plasma membrane of the
cell from which it budded, might provide cell attachment
activity. In fact, Moloney murine leukemia virus (MoMLV)
particles without any viral glycoproteins are able to bind
to target cells (Pizzato et al., 1999). It is possible that a
similar type of nonvirally encoded binding activity might
be present in RSV virions. Glycoprotein-less virions have
been produced in the case of MoMLV by transfection of
a cDNA copy of the viral genome lacking the env gene.
It is not yet possible to generate the quantity of RSV
virions needed for such an experiment directly from a
transfection.
During the course of our experiments, Feldman et al.
(2000) reported the effects of heparin and heparinase on
cp52 virion binding and infection compared to RSV A2.
Karger et al. (2001) also reported that heparin inhibits
infection of recombinant bovine RSV expressing only the
F protein, as well as virus expressing all three glycopro-
teins. In general, their findings were qualitatively similar
to ours, but differed quantitatively in that they did not
describe the lower GAG dependence of viruses express-
ing only the F protein. Both of these reports used 10-fold
dilutions of heparin in their blocking experiments and
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may have missed the quantitative differences that we
found by using more closely spaced, twofold dilutions. In
comparing cp52 (subtype B) with RSV A2 (subtype A), the
difference in subtype may also have made comparison
difficult. It is also possible that novel aspects of cp52,
such as the amino acid substitution in the F protein
relative to its subtype B parent, may have compensated
for the loss of the G protein. The use of different cell
lines, Vero in their experiments and HEp-2 in ours, could
also have been important. For instance, HSV-1 displays
different entry kinetics, plaquing efficiency, and heparin
sensitivity between these two cell lines (McClain and
Fuller, 1994).
The present report has also extended the comparison
of rgRSV-F and rgRSV-SGF binding activity to other sul-
fate groups on heparin by using soluble modified hepa-
rin, examined the importance of IdoA through pretreating
cells with bFGF, and confirmed the importance of HS and
its N-sulfate modification using CHO cell mutants. Fur-
thermore, our comparison of rgRSV-F and rgRSV-SGF
binding to CHO and GAG-deficient CHO cells led to a
model for the RSV G and F protein binding activities. In
each of these experiments, the GAG characteristics im-
portant for rgRSV-F and rgRSV-SGF binding were similar,
suggesting that both viruses bind to HS in a similar
manner. It is noteworthy that Feldman et al. (2000), using
extremely high heparin concentrations (500 g/ml),
could not prevent the final 10% of the binding of either
cp52 or RSV A2, consistent with all of our results and
with the suggestion of an alternative attachment mech-
anism, perhaps via an F receptor. A recent study sug-
gested intercellular adhesion molecule-1 (ICAM-1) as a
possible candidate receptor for RSV, suggesting that
ICAM-1 binds to the F protein (Behera et al., 2001).
MATERIALS AND METHODS
Cell lines and media
The human tumor-derived epithelial cell line, HEp-2,
was obtained from the American Type Culture Collection
and maintained in OptiMEM (GIBCO BRL) supplemented
with 2% fetal bovine serum (FBS). The parental and
mutant Chinese hamster ovary (CHO) cell lines, K1, pgsA-
745, pgsE606, and pgsF-17, were kindly provided by Jeff
Esko (University of California at San Diego), and main-
tained in F12 medium (GIBCO BRL) supplemented with
10% FBS. All cell lines were incubated at 37°C in 5% CO2.
Chemicals and enzymes
Bovine lung heparin, porcine intestinal heparan sul-
fate, heparinase I (EC4.2.2.7), heparitinase (heparinase
III) (EC4.2.2.8), and human recombinant bFGF were ob-
tained from Sigma Chemical Co. (St. Louis, MO). Bovine
intestinal heparin and its chemically modified heparins
were obtained from Neosparin, Inc. (San Leandro, CA).
Cell binding and infectivity assays
Confluent monolayers of HEp-2 or CHO cells were
seeded in 12-well plates 24 h prior to virus exposure.
Cells were inoculated with rgRSV-SGF or rgRSV-F that
had been metabolically labeled with Tran35S-label (ICN)
and purified by two cycles of sucrose gradient centrifu-
gation, as previously described (Techaarpornkul et al.,
2001). Virus was diluted in MEM, 1% bovine serum albu-
min (BSA) to 3  105 cpm/ml, and 100 l was added to
the cells at 4°C for 1 h (CHO cells) or 1.5 h (HEp-2 cells),
rocking every 10 min. After binding, the inoculum was
removed and the monolayers were washed four times
with ice-cold MEM. For binding assays, cells were lysed
with RIPA buffer (10 mM Tris pH 7.5, 150 mM NaCl, 1%
sodium deoxycholate, 1% Triton X-100, 0.1% SDS) and the
amount of labeled virus bound was determined by scin-
tillation counting (Bio-Safe II, Research Products Interna-
tional Corp.) in a 1215 Rack Beta II Liquid Scintillation
Counter (Pharmacia LKB).
To assay infectivity, growth medium was added and
the plates were moved to 37°C. After incubation for 18 h,
cells were trypsinized, washed once with PBS, and fixed
with 3% paraformaldehyde, and the percentage of in-
fected (green fluorescent) cells were counted by flow
cytometer (Ortho Cytoronabsolute).
Soluble GAGs and enzyme digestions
Heparin, several chemically modified heparins, and
HS were dissolved and diluted in OptiMEM, prior to
mixing them with virus. Heparinase I and heparitinase
were dissolved in buffer (PBS pH 7.5, 1 mM CaCl2, 1.5
mM MgCl2, 0.1% glucose, and 0.1% BSA) containing pro-
tease inhibitors (100 mM PMSF, 10 g/ml leupeptin, 2
g/ml aprotinin, and 10% FBS). Cells were treated with
the enzyme at 20°C for 1 h, followed by 1 h at 37°C in 5%
CO2. After treatment, the enzyme was removed and the
cells were washed three times with cold MEM before
performing the binding and infectivity assays.
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